D-penicillamine-induced lupus erythematosus patient polyarthritis pleurisy rash positive antinuclear antibody result years D-penicillamine therapy D-penicillamine-induced antinuclear antibodies high-titer IgG -DNA complex Weak IgM activity Withdrawal D-penicillamine therapy improvement clinical symptoms gradual resolution serologic abnormalities 